Literature DB >> 16188808

Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I.

Suresh Vijay1, J Ed Wraith.   

Abstract

AIM: To review the heterogeneity and severity of the clinical features at the attenuated end of the mucopolysaccharidosis (MPS) type I disease spectrum.
METHODS: The course of disease in 29 patients with attenuated mucopolysaccharidosis I who attended the MPS clinic in Manchester, UK, was reviewed.
RESULTS: For more than half of the patients, onset of symptoms was in the first 2 y of life, and the age at diagnosis ranged from 15 mo to 40 y. Joint stiffness, corneal clouding, umbilical hernia and recurrent ear, nose and throat symptoms were the commonest features at presentation. Patients experienced significant morbidity during the course of this inherited disease. Skeletal problems predominated and cardiac valve pathology, upper airway obstruction and hearing deficits were detected in a notable number of patients. Nerve decompression for carpal tunnel syndrome, cervical cord decompression, and grommet insertion for serous otitis media were the most frequent surgical interventions.
CONCLUSION: Clinical presentation of attenuated ("non-Hurler") mucopolysaccharidosis type I is heterogeneous in time of onset and types of clinical features. A better understanding of the spectrum of disease and of the related disease progression will contribute to more accurate diagnosis, and patients will benefit from early intervention.

Entities:  

Mesh:

Year:  2005        PMID: 16188808     DOI: 10.1111/j.1651-2227.2005.tb02004.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  45 in total

Review 1.  [Lysosomal storage diseases].

Authors:  B Manger
Journal:  Z Rheumatol       Date:  2010-08       Impact factor: 1.372

2.  Intrathecal gene therapy corrects CNS pathology in a feline model of mucopolysaccharidosis I.

Authors:  Christian Hinderer; Peter Bell; Brittney L Gurda; Qiang Wang; Jean-Pierre Louboutin; Yanqing Zhu; Jessica Bagel; Patricia O'Donnell; Tracey Sikora; Therese Ruane; Ping Wang; Mark E Haskins; James M Wilson
Journal:  Mol Ther       Date:  2014-07-16       Impact factor: 11.454

3.  Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis I.

Authors:  Visnja Tokic; Ingeborg Barisic; Nevenka Huzjak; Giorgie Petkovic; Ksenija Fumic; Eduard Paschke
Journal:  Eur J Pediatr       Date:  2006-10-17       Impact factor: 3.183

4.  Neonatal Systemic AAV Induces Tolerance to CNS Gene Therapy in MPS I Dogs and Nonhuman Primates.

Authors:  Christian Hinderer; Peter Bell; Jean-Pierre Louboutin; Yanqing Zhu; Hongwei Yu; Gloria Lin; Ruth Choa; Brittney L Gurda; Jessica Bagel; Patricia O'Donnell; Tracey Sikora; Therese Ruane; Ping Wang; Alice F Tarantal; Margret L Casal; Mark E Haskins; James M Wilson
Journal:  Mol Ther       Date:  2015-05-29       Impact factor: 11.454

5.  Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I.

Authors:  Janet A Thomas; Michael Beck; Joe T R Clarke; Gerald F Cox
Journal:  J Inherit Metab Dis       Date:  2010-06-02       Impact factor: 4.982

Review 6.  Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.

Authors:  Sun H Peck; Margret L Casal; Neil R Malhotra; Can Ficicioglu; Lachlan J Smith
Journal:  Mol Genet Metab       Date:  2016-06-04       Impact factor: 4.797

Review 7.  Mucopolysaccharidoses.

Authors:  Rolando Cimaz; Francesco La Torre
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

8.  An exploratory study of brain function and structure in mucopolysaccharidosis type I: long term observations following hematopoietic cell transplantation (HCT).

Authors:  Elsa Shapiro; O Evren Guler; Kyle Rudser; Kathleen Delaney; Kendra Bjoraker; Chester Whitley; Jakub Tolar; Paul Orchard; James Provenzale; Kathleen M Thomas
Journal:  Mol Genet Metab       Date:  2012-07-20       Impact factor: 4.797

9.  Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis.

Authors:  Rolando Cimaz; Giovanni Valentino Coppa; Isabelle Koné-Paut; Bianca Link; Gregory M Pastores; Maria Rua Elorduy; Charles Spencer; Carter Thorne; Nico Wulffraat; Bernhard Manger
Journal:  Pediatr Rheumatol Online J       Date:  2009-10-23       Impact factor: 3.054

10.  Cardiac abnormalities in adults with the attenuated form of mucopolysaccharidosis type I.

Authors:  O I I Soliman; R G M Timmermans; A Nemes; W B Vletter; J H P Wilson; F J ten Cate; M L Geleijnse
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.